Adenovirus vaccine (Bharat Biotech)

N/A

Report date: 2026/05/07 20:00:36

Base Information

Drug NameAdenovirus vaccine (Bharat Biotech)
Drug Alias NameIntranasal COVID-19 vaccine (Washington University School of Medicine)iNCOVACC (Bharat Biotech)SARS-CoV-2 Vaccine (Bharat Biotech)BBV-154OCU-500
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Coronavirus Infections
Global Approved IndicationsCoronavirus Disease 2019 (COVID-19)
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2022/12/01
Country/TerritoryUnited StatesEuropeIndia +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesWashington University School Of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesOcugen IncBharat Biotech International LtdNational Institute Of Allergy And Infectious Diseases (Niaid)
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Coronavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A